Filter
110
Filtered Results: 110
Text search:
Yap,
J.
Featured
Recommendations
13
New Publications
39
Language
Document type
No document type
54
Guidelines
26
Studies & Reports
13
Manuals
5
Fact sheets
5
Training Material
4
Strategic & Response Plan
2
Situation Updates
1
Countries / Regions
Brazil
12
Mozambique
4
Global
4
India
4
Venezuela
3
Russia
3
Philippines
2
Africa
2
Haiti
2
Western and Central Europe
2
Angola
2
Nepal
1
Thailand
1
Kenya
1
Ukraine
1
Cameroon
1
Malawi
1
Guinea
1
Italy
1
Cambodia
1
Asia
1
Tanzania
1
Germany
1
South–East Asia Region
1
Paraguay
1
Bangladesh
1
Uganda
1
Indonesia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
COVID-19
13
Guidelines
10
Studies & Reports
6
Capacity Building
5
Vector Control
2
Disabilities
2
Parasitology
2
Non-communicable Diseases
2
Paediatrics
1
Hepatitis
1
Pharmacy & Technology
1
Sanitation
1
Cancer
1
Cancer Treatment & Resources
1
Pediatrics
1
Medical Devices & Equipment
1
Policies
1
Drugs & Medical Equipment
1
Humanitarian Crisis
1
Palliative Care
1
Mental Health
1
COPD/Asthma
1
Maternal Health
1
Dengue
1
Age & Elderly
1
Neonatal Care
1
Reproductive Health
1
Toolboxes
Country specific documents
9
Inactivated COVID-19 Vaccines
9
Gynaecology / Obstetrics
8
Context & Facts
8
Travel Medicine
6
Health Systems
5
Immunization Guidelines
5
For Pregnant Women
4
Biontech/Pfizer Comirnaty
4
Preparedness & Prevention
4
Microcephaly
3
Clinical Guidelines
3
Zika Prevention & Control
3
Training Material
2
Children/Adolescents Mental Disorders
2
Research
2
Training Supporting Material mhGAP
2
Gender Aspects
2
Moderna
2
Covaxin
2
Climate Change General
2
Neurological Disorders
2
Paediatrics
2
Mental Health GAP Action Programme
2
Reports & Studies
2
Neurological disorders, Others
2
Eastern Europe and central Asia
2
Alcohol
1
ART Drug Resistance
1
HIV testing & services
1
Guillain-Barré Syndrome
1
Policies & Programmes
1
Training Manuals
1
Substance Use Disorders, Others
1
Hepatitis
1
Public Health
1
Surveillance
1
Disability
1
Studies & Reports
1
Global
1
Epilepsy
1
Sustainable Development Goals
1
IEC Substance Use Disorders
1
Clinical Guidelines
1
Context & Facts, Travel Advice
1
PPE Personel Protective Equipment
1
Surveillance & Contact tracing
1
Faith-based Organizations
1
Global Impact: Socio-economic, health services, TB & HIV
1
Paediatrics
1
Hospital Readiness/Essential Health Services
1
Access & Strategy
1
Logistics & Supply
1
Vector-based Vacines General
1
Vaxzevria (Astra Zeneca)
1
Johnson & Johnson
1
Rational use of Medicine
1
Strategies
1
Epilepsy
1
Pharmacovigilance
1
WASH Water Sanitation & Hygiene
1
Studies & Reports
1
Studies & Reports
1
Overview, Studies & Reports
1
General Information
1
General Information & Methodology
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Risk Factors
1
others
1
Substance Use Disorders & Addiction
1
National Emergency Response Plans
1
Asia
1
Dengue Prevention & Control
1
Reports & Studies Children HIV
1
Planetary Health
1
Epidemiology
1
Global Health Financing
1
Laboratory & Diagnostics
1
Depression
1
Studies & Reports
1
Universal Health Coverage & Primary Health Care
1
Food & Nutrition
1
Risk Communication & Community Engagement
1
Plague Prevention & Control
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat...
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been ...
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
These WHO interim recommendations for use of the COVID-19 vaccine BIBP produced by Sinopharm were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
Th...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
first issued 18 August 2022
Update, 23 de junio de 2022
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
PLoS Neglected Tropical Diseases https://doi.org/10.1371/journal.pntd.0004762
This study shows the importance of an integrated entomological and medical surveillance for the evaluation of arboviral disease risk, which is a precondition for designing cost-effective vector control programs.
Organización Mundial de la Salud. (2022). Recomendaciones provisionales sobre el uso de la vacuna CanSinoBIO Ad5-nCoV-S [recombinante] (Convidecia™) contra la COVID-19: orientaciones provisionales, primera publicación: 19 de mayo de 2022.
Past quantitative research on health financing has focused mostly on the level and distribution of total expenditure, with little emphasis on the specific role of public funds, despite their known importance for universal health coverage (UHC). Health Accounts data do not disaggregate public expendi...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
